Valued at a market cap of $41.2 billion, Corteva, Inc. (CTVA) operates in the agriculture business and develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. The Indianapolis, Indiana-based company also supplies products to enhance crop health and protect crops against weeds, insects, and other pests and diseases. It is expected to announce its fiscal Q3 earnings results after the market closes on Wednesday, Nov. 6.
Ahead of this event, analysts project the agricultural chemical company to report a loss of $0.31 per share, higher by 34.8% from a loss of $0.23 per share in the year-ago quarter. The company has consistently beaten Wall Street's bottom-line estimates in the last four quarters.
-copy-dd1f2bf0.jpeg?w=600)
